Moore Capital Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Buy |
+20,000
| New | +$2.56M | 0.03% | 257 |
|
|
2022
Q4 | – | Sell |
-226,782
| Closed | -$14.9M | – | 545 |
|
|
2022
Q3 | $14.9M | Buy |
+226,782
| New | +$14.9M | 0.35% | 43 |
|
|
2022
Q1 | – | Sell |
-38,654
| Closed | -$4.14M | – | 739 |
|
|
2021
Q4 | $4.14M | Sell |
38,654
-126,415
| -77% | -$13.5M | 0.08% | 248 |
|
|
2021
Q3 | $17M | Sell |
165,069
-29,114
| -15% | -$2.99M | 0.26% | 69 |
|
|
2021
Q2 | $17.1M | Buy |
194,183
+77,272
| +66% | +$6.8M | 0.24% | 72 |
|
|
2021
Q1 | $11.4M | Sell |
116,911
-88,543
| -43% | -$8.61M | 0.14% | 104 |
|
|
2020
Q4 | $23M | Buy |
205,454
+85,802
| +72% | +$9.62M | 0.25% | 47 |
|
|
2020
Q3 | $11.1M | Buy |
119,652
+94,652
| +379% | +$8.77M | 0.21% | 85 |
|
|
2020
Q2 | $1.95M | Buy |
+25,000
| New | +$1.95M | 0.05% | 180 |
|
|
2018
Q1 | – | Sell |
-35,000
| Closed | -$2.64M | – | 228 |
|
|
2017
Q4 | $2.64M | Buy |
+35,000
| New | +$2.64M | 0.05% | 156 |
|